GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (FRA:Q9T) » Definitions » Beginning Cash Position

ME Therapeutics Holding (FRA:Q9T) Beginning Cash Position : €0.89 Mil (As of Feb. 2025)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Beginning Cash Position?

ME Therapeutics Holding's Beginning Cash Position for the quarter that ended in Feb. 2025 was €0.89 Mil.

ME Therapeutics Holding's quarterly Beginning Cash Position declined from Aug. 2024 (€1.09 Mil) to Nov. 2024 (€1.01 Mil) and declined from Nov. 2024 (€1.01 Mil) to Feb. 2025 (€0.89 Mil).

ME Therapeutics Holding's annual Beginning Cash Position declined from Aug. 2022 (€0.06 Mil) to Aug. 2023 (€0.05 Mil) but then increased from Aug. 2023 (€0.05 Mil) to Aug. 2024 (€0.43 Mil).


ME Therapeutics Holding Beginning Cash Position Historical Data

The historical data trend for ME Therapeutics Holding's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Beginning Cash Position Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23 Aug24
Beginning Cash Position
0.06 0.05 0.43

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.99 1.22 1.09 1.01 0.89

ME Therapeutics Holding Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


ME Therapeutics Holding Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding Business Description

Traded in Other Exchanges
Address
177 Robson St., Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding Headlines

No Headlines